JNJ-67953964 clinical trials

An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)

This study is testing a new medicine, JNJ-67953964, for adults with depression. It aims to see if it's safe and effective when added to their usual treatment over a long period. We'll monitor health, mood, and any side effects.